![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CYNTELLECT RECEIVES $2.2 MILLION MILESTONE PAYMENT FROM SIGMA-ALDRICH CORPORATION
CYNTELLECT RECEIVES $2.2 MILLION MILESTONE PAYMENT FROM SIGMA-ALDRICH CORPORATION
June 7, 2006
Cyntellect, Inc., a privately-held biotechnology company, today announced that it has received a $2.2 million equity purchase milestone payment from Sigma-Aldrich. The milestone payment represents Cyntellect's satisfaction of certain terms and conditions under the two companies' exclusive Cell Xpress service commercialization agreement executed one year ago.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-07-2006/0004376019&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct